Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer
Alexandra M. Sharp(The University of Texas at San Antonio Health Science Center), David A. Morilak(The University of Texas at San Antonio Health Science Center), Denisse Paredes(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Samantha S. Yee(The University of Texas at San Antonio Health Science Center), Michael A. Liss(University of San Diego), Anna Campbell Sullivan(The University of Texas at San Antonio Health Science Center), April L. Risinger(The University of Texas at San Antonio Health Science Center), Suphada Lertphinyowong(The University of Texas at San Antonio Health Science Center), Teresa L. Johnson‐Pais(The University of Texas at San Antonio Health Science Center), Robin J. Leach(The University of Texas at San Antonio Health Science Center), Ian M. Thompson(The University of Texas at San Antonio Health Science Center)
Cited by 11
Related Papers
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845